Association of Dipeptidyl Peptidase-4 Inhibitor Use and Amyloid Burden in Patients With Diabetes and AD-Related Cognitive Impairment.

Seong Ho JeongHye Ryun KimJeonghun KimHankyeol KimNamki HongJin Ho JungKyoungwon BaikHanna ChoChul Hyoung Lyoo Byoung Seok YeYoung H SohnJoon-Kyung SeongPhil Hyu Lee

Published in: Neurology (2021)

These findings suggest that DPP-4i use is associated with low amyloid burden and favorable long-term cognitive outcome in diabetic patients with ADCI.

Keyphrases

cognitive impairment
type diabetes
risk factors
wound healing